0%
0%
0%
0%
0%
About AcelRx Pharmaceuticals, Inc
Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Vincent J. Angotti
Website
acelrx.com
Headquarters
Hayward
Employees
19
Founded
2005
ISIN
US00444T2096
AcelRx Pharmaceuticals, Inc. engages in the development and commercialization of therapies use in medically supervised settings. The firm's portfolio includes DSUVIA, DZUVEO, Zalviso, ARX-02 and ARX-03. The company was founded by Thomas A. Schreck and Pamela Pierce Palmer on July 13, 2005 and is headquartered in Hayward, CA.
ACRX Daily Long Double Bottom Bullish Long TermACRX has reached the lowest price @.46 a share, it has also double bottomed on the daily, the daily candle is bullish .. Looking to ride this buy for a long term.
Going to ride it up to the red resistance trendline, if it becomes support it should reach $2 to $4. Happy New Year..
ACRX Daily Long Double Bottom Bullish Long TermACRX has reached the lowest price @.46 a share, it has also double bottomed on the daily, the daily candle is bullish.. Looking to ride this buy for a long term.
Going to ride it up to the red resistance trendline, if it becomes support it should reach $2 to $4. Happy New Year..
AcelRx Pharmaceuticals Price TargetsACRX AcelRx Pharmaceuticals is a specialty pharmaceutical company that focuses on the development and commercialization of therapies for the treatment of acute pain.
52 Week Range 0.65 - 2.94
Sitting at all time low now.
HC Wainwright has a 5usd price target for it.
My take profits are:
1: $0.95
ACRX BullishI feel like ACRX is bullish. It is biomed/growth stock season and this one has great technicals and price support. i bought a few.
ACRX LONGEntering here at 1.38. Feels like there's room to run upwards. Did some DD, and unlike many other pharmaceutical companies that get pumped and dumped, these guys actually have a legit product. High risk, high reward trade.
ACRX LongHook Reversal
In Demand Zone
Entry 1.38
Stop 1.2
Target 2.25
I am not a PRO trader. I trade option to test my trading plan with small cost.
The max Risk of each plan is less than 1% of my account.
If you like this idea, please use SIM/Demo account to try it.
$ACRX to 7$ In December AcelRx published clinical data in „The Journal of Universal Surgery“ titled „A Medication Use Evaluation of Sufentanil Sublingual Tablet 30 mcg for the Perioperative Management of Surgical Pain“.
What is DSUVIA? According to AcelRx DSUVIA is a recently approved drug „indicated for use i
$ACRX can rise in the next daysContextual immersion trading strategy idea.
AcelRx Pharmaceuticals is a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain.
The demand for shares of the company looks higher than the supply.
This and other conditions can
See all ideas
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
